WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Triggering global regulatory submissions this year for the treatment of obesity
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Fourteenth breakthrough therapy designation granted by FDA across the oncology portfolio of Daiichi Sankyo
The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
Subscribe To Our Newsletter & Stay Updated
